SCHEMBL9344339

SCHEMBL9344339

O=C1c2ccccc2CCC1CCCC(=O)N1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.50
HTR2C P28335 3/20 0.49
ACHE P22303 1/20 0.46
CYP19A1 P11511 1/20 0.46
FKBP1A P62942 1/20 0.45
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HTR1A P08908 2/20 0.44
SIGMAR1 Q99720 2/20 0.44
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8536631 0.90 HTR2C (0.52) HTR2CACHECYP19A1ALDH1A1HPGD
SCHEMBL8532071 0.88 ACHE (0.52) SMN1; SMN2HTR2CACHECYP19A1ALDH1A1
SCHEMBL9344141 0.86 HTR2C (0.49) LMNASMN1; SMN2HTR2CACHECYP19A1
SCHEMBL8534917 0.85 ACHE (0.51) SMN1; SMN2HTR2CACHECYP19A1ALDH1A1
SCHEMBL8536658 0.81 HTR2C (0.50) HTR2CACHECYP19A1ALDH1A1HPGD
SCHEMBL8536795 0.79 CYP19A1 (0.54) SMN1; SMN2HTR2CACHECYP19A1ALDH1A1
SCHEMBL7167409 0.75 CYP19A1 (0.53) SMN1; SMN2HTR2CACHECYP19A1ALDH1A1
SCHEMBL27646285 0.75 SIGMAR1 (0.68) HTR2CACHECYP19A1HTR1ASIGMAR1
SCHEMBL27582477 0.74 CYP19A1 (0.52) SMN1; SMN2HTR2CACHECYP19A1ALDH1A1
SCHEMBL7672871 0.73 CYP19A1 (0.57) SMN1; SMN2HTR2CACHECYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5292768-A Compound effective as cerebral insufficiency improver SUNTORY LIMITED (JP) 1994-03-08 US disclosed
US-5288752-A Brain disorders SUNTORY LIMITED (JP) 1994-02-22 US disclosed
EP-0322248-B1 COMPOUNDS EFFECTIVE AGAINST CEREBRAL INSUFFICIENCY SUNTORY LIMITED (JP) 1993-08-04 EP disclosed
US-5179092-A Cognition activators SUNTORY LIMITED (JP) 1993-01-12 US disclosed
US-5057514-A Compounds effective as cerebral schemia treating agents SUNTORY LIMITED (JP) 1991-10-15 US disclosed
EP-0322248-A2 Compounds effective against cerebral insufficiency SUNTORY LIMITED (JP) 1989-06-28 EP disclosed